Keywords: novartis, granted, first, approval, simulect, been, worldwide

Novartis Granted First Approval For Simulect

Article | 16 April 1998

Print This

Novartis has been granted the first worldwide approval, in Switzerland,for its new antibody product for the prevention of acute ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in